Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression

Clinically silent corticotroph tumors are usually macroadenomas that comprise 20% of ACTH tumors. They frequently progress to aggressive tumors with high recurrence, invasiveness, and on rare occasions, they may become hormonally active causing Cushing’s disease. Trustable biomarkers that can predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Demarchi, Gianina, Perrone, Sofía, Esper Romero, Gaela, De Bonis, Cristian, Casasco, Juan Pablo, Sevlever, Gustavo, Berner, Silvia Ines, Cristina, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344046/
https://www.ncbi.nlm.nih.gov/pubmed/35928898
http://dx.doi.org/10.3389/fendo.2022.870172

Ejemplares similares

Ejemplares similares